Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cell Therapy Holdings LLC has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. The current prosecution is handled by 1 distinct examiner and 1 distinct art unit. This suggests that the company's intellectual property efforts are currently focused on a single technological advancement within this broad category. Working within 1 distinct art unit allows the company to engage with a specific group of examiners who are experts in that particular field of medical devices.
The busiest examiner for the portfolio is DORNA, CARRIE R, who is responsible for the 1 pending office action. This represents a consolidated prosecution effort within a single administrative unit, with no other examiners currently reviewing the company's applications. Since the busiest examiner is only handling 1 pending office action, the portfolio is in a very streamlined state. This concentration simplifies the prosecution strategy but means the outcome of the company's current patent efforts depends entirely on this examiner's review.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DORNA, CARRIE R | 1 | 72.3% | +27.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18604611 | METHOD OF PRODUCING A PERIPHERAL BLOOD MONONUCLEAR CELL COMPOSITION SUITABLE FOR REPAIRING OR ENGINEERING A TISSUE | DORNA, CARRIE R | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18604611 | METHOD OF PRODUCING A PERIPHERAL BLOOD MONONUCLEAR CELL COMPOSITION SUITABLE FOR REPAIRING OR ENGINEERING A TISSUE | DORNA, CARRIE R | 3791 | §112DP | Non-Final OA | — | Pending | Mar 14, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCell Therapy Holdings LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Carrie R Dorna has the most, with 1 of Cell Therapy Holdings LLC's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
